Symbols

SENS

Senseonics Holdings·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 1

Bearish signal 0

Revenue Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SENS

Senseonics Holdings, Inc.

A medical technology company specializing in the development and manufacturing of blood glucose monitoring products

Industry

Healthcare Equipment and Supplies

Established Date

06/26/2014

Listing Date

11/17/2025

Exchange

NASDAQ Stock Exchange

Full-time Employees

117

Fiscal Year Ends

12-31

Website

www.senseonics.com

Security Type

Common stock

Office address

20451 Seneca Meadows Parkway, Germantown, MD 20876-7005

Business

Introduction

Senseonics Holdings, Inc., was originally incorporated in Nevada on June 26, 2014. On December 4, 2015, the company was re-incorporated in Delaware. The company is a medical technology company focused on developing and manufacturing blood glucose monitoring products designed to change the lives of the global diabetes community with differentiated, long-term implantable blood glucose management technology. The company's implantable CGMs, including the Eversense E3 continuous blood glucose monitoring system version, are designed to continuously and accurately measure blood glucose levels in diabetic patients through subcutaneous sensors, detachable and rechargeable smart transmitters, and convenient applications for real-time diabetes monitoring and management for up to six months, compared to seven to 14 days for non-implantable CGM systems.

Company Financials

EPS

SENS has released its 2025 Q3 earnings. EPS was reported at -0.43, versus the expected -0.02, missing expectations. The chart below visualizes how SENS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SENS has released its 2025 Q3 earnings report, with revenue of 8.10M, reflecting a YoY change of 89.89%, and net profit of -19.53M, showing a YoY change of 18.54%. The Sankey diagram below clearly presents SENS's revenue sources and cost distribution.